These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 3261822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V, Hilbert D, Wolff L.
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [Abstract] [Full Text] [Related]

  • 4. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
    Atencio IA, Belli B, Hobbs M, Cheng SF, Villarreal LP, Fan H.
    Virology; 1995 Oct 01; 212(2):356-66. PubMed ID: 7571405
    [Abstract] [Full Text] [Related]

  • 5. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec 01; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P, Collavo D, Ronchese F, De Rossi A, Biasi G, Chieco-Bianchi L.
    Immunology; 1984 Jan 01; 51(1):9-16. PubMed ID: 6228521
    [Abstract] [Full Text] [Related]

  • 9. Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.
    Biasi G, Facchinetti A, Panozzo M, Zanovello P, Chieco-Bianchi L, Collavo D.
    J Immunol; 1991 Oct 01; 147(7):2284-9. PubMed ID: 1833453
    [Abstract] [Full Text] [Related]

  • 10. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK, Okimoto M, Kulkarni V, Lander JK, Fan H.
    Virology; 1998 Mar 01; 242(1):60-7. PubMed ID: 9501051
    [Abstract] [Full Text] [Related]

  • 11. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC, Burakoff SJ, Faller DV.
    J Immunol; 1986 Dec 15; 137(12):3968-72. PubMed ID: 3491152
    [Abstract] [Full Text] [Related]

  • 12. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P, Gisselbrecht S, Boyer B, Levy JP.
    Blood Cells; 1981 Dec 15; 7(2):301-11. PubMed ID: 6975141
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ, Howe ML.
    J Immunol; 1979 May 15; 122(5):1874-80. PubMed ID: 221580
    [Abstract] [Full Text] [Related]

  • 14. Effects of murine leukemia viruses on the function of dendritic cells.
    Gabrilovich DI, Roberts MS, Harvey JJ, Botcherby M, Bedford PA, Knight SC.
    Eur J Immunol; 1993 Nov 15; 23(11):2932-8. PubMed ID: 8223870
    [Abstract] [Full Text] [Related]

  • 15. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M, Valk PJ, Vankan Y, de Both N, Löwenberg B, Delwel R.
    Virology; 2000 Mar 15; 268(2):308-18. PubMed ID: 10704339
    [Abstract] [Full Text] [Related]

  • 16. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice.
    Greenberger JS, Shadduck RK, Jaenisch R, Waheed A, Sakakeeny MA.
    Cancer Res; 1981 Sep 15; 41(9 Pt 1):3556-65. PubMed ID: 6266658
    [Abstract] [Full Text] [Related]

  • 17. Murine leukemia virus induced central nervous system diseases.
    Wong PK, Shikova E, Lin YC, Saha K, Szurek PF, Stoica G, Madden R, Brooks BR.
    Leukemia; 1992 Sep 15; 6 Suppl 3():161S-165S. PubMed ID: 1602815
    [Abstract] [Full Text] [Related]

  • 18. Involvement of the spleen in preleukemic development of a murine retrovirus-induced promonocytic leukemia.
    Nason-Burchenal K, Wolff L.
    Cancer Res; 1992 Oct 01; 52(19):5317-22. PubMed ID: 1394137
    [Abstract] [Full Text] [Related]

  • 19. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb 01; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.